## Abstract ## Background We proposed to exploit hypoxia‐inducible factor (HIF)‐1α overexpression in prostate tumours and use this transcriptional machinery to control the expression of the suicide gene cytosine deaminase (CD) through binding of HIF‐1α to arrangements of hypoxia response elements.
The molecular basis of the hypoxia response pathway: Tumour hypoxia as a therapy target
✍ Scribed by Christine Blancher; Adrian L. Harris
- Book ID
- 110231193
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 547 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0167-7659
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Nitric oxide‐donating non‐steroidal anti‐inflammatory drugs are safer than traditional NSAIDs and inhibit the growth of prostate cancer cells with greater potency than NSAIDs. __In vivo__, prostate cancer deposits are found in a hypoxic environment which induces resistance to chemothera
Combined radioimmunotherapy (RAIT) and hypoxic cytotoxin therapy (SR4233 or NLCQ-1) have been evaluated with both modalities administered on the same day with only moderate improvement compared with the effects of RAIT alone. In a series of studies using oxygen electrodes, immunohistochemistry and r